Medical Data Company OneMedNet Latest to Pursue Bitcoin Treasury Strategy After Capital Raise

One of the investors was Off The Chain Capital, a cryptocurrency investment firm connected to Bloq Chairman Matthew Roszak and Fortress founder Rob Kauffman. This fund bought a mix of shares and warrants for ONMD, which is another way of saying they invested in ONMD’s stock options.

Over the past year, OneMedNet’s stock value has dropped by over 90% following its initial public offering through a Special Purpose Acquisition Company (SPAC) deal.

In simpler terms, Brian Dixon, the CEO of Off The Chain Capital, stated that this opportunity, if executed successfully, could potentially surpass Bitcoin’s performance. As investors, our aim is to find undervalued or discounted opportunities, and we strive diligently to outshine Bitcoin’s returns.

According to Dixon’s perspective, investing a portion of cash held by public companies into Bitcoin could potentially yield more value for shareholders compared to traditional investments such as real estate, stocks, or bonds.

“He stated that it seems increasingly likely that more public companies will come to realize that not investing their excess cash into bitcoin is not financially savvy from a fiduciary perspective when considering their treasury reserve strategy.”

As a long-term investor with extensive experience in the financial markets, I find myself in agreement with Off the Chain and OneMedNet, as well as Michael Saylor’s approach to Bitcoin investment. Having observed MicroStrategy’s (MSTR) impressive stock performance since it began incorporating cryptocurrency into its balance sheet in August 2020, I believe that this strategy has been highly effective.

As a financial analyst, I’ve noticed that both U.S.-based Semler Scientific and Japanese company Metaplanet, which are publicly traded entities, seem to be following comparable strategies in their respective industries.